Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

Recognition Follows Claimable's Launch of GLP-1 Support, Helping Patients Navigate One of the Most Denied Treatments in the U ...